Venture Certified
| 기술평가보증기업(기금) | 2018-11-26 ~ 2020-11-25 | 20180113436 | 2018-11-26 |
| 기술평가보증기업(기금) | 2020-11-26 ~ 2022-11-25 | 20200115177 | 2018-11-26 |
| 벤처투자유형 | 2022-11-26 ~ 2025-11-25 | 20221102010005 | 2018-11-26 |
| 벤처투자유형 | 2025-11-26 ~ 2028-11-25 | 20251104010004 | 2018-11-26 |
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 0.0B | 0.0B |
| Operating Profit | -7.6B | -10B | -11B |
| Net Profit | -10B | -10B | -11B |
| Total Assets | 17B | 18B | 18B |
| Total Liabilities | 23B | 14B | 4.0B |
| Total Equity | -6.2B | 4.1B | 14B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -8B
3 Consecutive Years of Net Loss
- 0.0%
▲ 29.2%
▼ 302.4%
▲ 203.1%
| Name | Position | Role |
|---|---|---|
| 노성구 | 대표이사 | 대표 |
| Regular Employees | 2persons |
| CEO | 노성구 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "경기 성남시",
"ceo_name": "노성구",
"certificate": [
{
"cert_number": "20180113436",
"changes": "",
"disclosure_date": "2018-11-26",
"first_cert_date": "2018-11-26",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-11-26 ~ 2020-11-25"
},
{
"cert_number": "20200115177",
"changes": "",
"disclosure_date": "2020-11-23",
"first_cert_date": "2018-11-26",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-11-26 ~ 2022-11-25"
},
{
"cert_number": "20221102010005",
"changes": "",
"disclosure_date": "2022-11-02",
"first_cert_date": "2018-11-26",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2022-11-26 ~ 2025-11-25"
},
{
"cert_number": "20251104010004",
"changes": "",
"disclosure_date": "2025-11-04",
"first_cert_date": "2018-11-26",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2025-11-26 ~ 2028-11-25"
}
],
"company_name": "파이메드바이오 주식회사",
"financials": {
"2022": {
"capital_stock": 552266000,
"cost_of_sales": 0,
"current_assets": 1498634000,
"current_liabilities": 189466000,
"gross_profit": 0,
"net_income": -1111010000,
"net_income_bs": -1111010000,
"non_current_assets": 327767000,
"non_current_liabilities": 212595000,
"non_operating_expenses": 8409000,
"non_operating_income": 25850000,
"operating_profit": -1128451000,
"revenue": 0,
"sga_expenses": 1128451000,
"total_assets": 1826401000,
"total_equity": 1424340000,
"total_liabilities": 402061000
},
"2023": {
"capital_stock": 552266000,
"cost_of_sales": 0,
"current_assets": 1521050000,
"current_liabilities": 163906000,
"gross_profit": 0,
"net_income": -1012523000,
"net_income_bs": -1012523000,
"non_current_assets": 300061000,
"non_current_liabilities": 1245388000,
"non_operating_expenses": 21808000,
"non_operating_income": 42032000,
"operating_profit": -1032747000,
"revenue": 0,
"sga_expenses": 1032747000,
"total_assets": 1821111000,
"total_equity": 411817000,
"total_liabilities": 1409294000
},
"2024": {
"capital_stock": 552266000,
"cost_of_sales": 0,
"current_assets": 1618138000,
"current_liabilities": 1052363000,
"gross_profit": 0,
"net_income": -1026848000,
"net_income_bs": -1026848000,
"non_current_assets": 72355000,
"non_current_liabilities": 1253161000,
"non_operating_expenses": 305143000,
"non_operating_income": 43229000,
"operating_profit": -764934000,
"revenue": 0,
"sga_expenses": 764934000,
"total_assets": 1690493000,
"total_equity": -615031000,
"total_liabilities": 2305524000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2022-02-28"
},
{
"amount": "1,000,043,100",
"changes": "1,000,043,100",
"date": "2022-02-28"
},
{
"amount": "9,000,000",
"changes": "9,000,000",
"date": "2020-03-31"
},
{
"amount": "309,408,350",
"changes": "309,408,350",
"date": "2020-03-31"
},
{
"amount": "300,000,000",
"changes": "300,000,000",
"date": "2019-10-29"
}
],
"phone": "031-8039-****",
"source": "pg_migration"
}{
"address": "경기도 성남시 분당구 돌마로 172 (정자동) 분당서울대학교병원 헬스케어혁신센터 2층 2233호",
"employee_count": 2,
"establishment_date": "20180401",
"source": "pg_migration",
"workplace_name": "파이메드바이오주식회사"
}Data Quality: 75/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | Public Data | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| comwel_insurance | 2026-03-05 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |